Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other Accumulated Expenses (2016 - 2025)

Palisade Bio has reported Other Accumulated Expenses over the past 14 years, most recently at $433000.0 for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 448.1% to $433000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $433000.0 through Dec 2025, up 448.1% year-over-year, with the annual reading at $433000.0 for FY2025, 448.1% up from the prior year.
  • Other Accumulated Expenses was $433000.0 for Q4 2025 at Palisade Bio, up from $202000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $433000.0 in Q4 2025 and troughed at $11000.0 in Q2 2022.
  • The 5-year median for Other Accumulated Expenses is $88000.0 (2022), against an average of $138933.3.
  • Year-over-year, Other Accumulated Expenses crashed 86.25% in 2022 and then soared 775.0% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $27000.0 in 2021, then skyrocketed by 225.93% to $88000.0 in 2022, then soared by 106.82% to $182000.0 in 2023, then crashed by 56.59% to $79000.0 in 2024, then soared by 448.1% to $433000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Accumulated Expenses are $433000.0 (Q4 2025), $202000.0 (Q3 2025), and $260000.0 (Q2 2025).